Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma

NCT07041827 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT07041827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07041827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma
Lead sponsor
The Netherlands Cancer Institute
Phase
Observational
Overall status
Completed
Start date
February 1, 2020
Completion date
February 1, 2023
Enrollment
217 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathies, cardiotoxicity, cardiovascular diseases, dlbcl, heart failure, late effect, metabolic syndrome, non hodgkin lymphoma, quality of life